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Mouse NIH :~T3 fibtoblast~ transfected with human colony stimulatin$ t'actor.I re.plOt produced diacyllilycerol in response to CSFI and this 
¢orrdated with elevated phosphatidylcholine hydrolyxinB activity measured in an in vitro assay, Treatment ~f cells with the isoflavone derivative 
~:enistein attenu~tted PC hydroly~;is n vitro ~ugilestin8 a role for CSFIR tyrosiae kiaase activity. A CSFIK mutan¢ laekin|l 67 amino acidi or the 
kinase inert domain, which may affect the ~ssociation of receptor with certain subitrale~, stimulated PC hydrolysis in response to CSFI. Couplinl; 
to PC hydrolysis is likely a $eneral property or CSFI R and the kinase inserl domain is dispensable for this activity. 
Colony sdmulatinit l'a¢tor- ! receptor; TI,'rosine kinase; Pho~phal dyleholine hydrol:tst~: NIH 3T] ¢oll 
I. INTRODUCTION 
Colony stimulating factor-1 is a lineage-specific 
hemopoietin required for tile maturation of cells of the 
mononuclear phagocyte lineage [1]. CSFI binds with 
high affinity to a 972 amino acid transmembrane recep- 
tor expressed on macro phages and their precursors [2]. 
CSFI binding stimulates receptor tyrosine kinase activi- 
ty and a host of cellular responses believed to be impor- 
tant in transducing receptor signals [1]. As with other 
members of the class III receptor tyrosine kinases 
(PDGFR and KIT), the CSFIR cytoplasmic kinase do- 
main is split into two segments by a hydrophilic se- 
quence of approximately 70 amino acids termed the 
kinase insert domain [2]. The K I domain of CSFI R may 
have an important role in substrate recognition, For ex- 
ample, KI domain deletion mutants of CSF1R 
associated poorly with phosphatidylinositol 3-kinase 
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[3,4], a novel enzyme with a possible role in growth 
regulation and transformation by viral oncogenes, 
Many polypeptide growth factors stimulate a 
phospholipase C that hydrolyzes phosphatidylinositol 
4,5-bisphosphate in the plasma membrane to yield in- 
ositol 1,4,5-trisphosphate and diacylglycerol [5]. IP~ 
stimulates release of Ca a* from intracellular stores 
while DAG activates protein kinase C [6]. A 
phosphatidylinositol.specific PLC is a direct substrate 
for PDGFR and EGFR [7], and tyrosine phosphoryla- 
tion of PLC ?1 correlates with increased activity toward 
PIP2 [8]. Despite structural similarities of CSFIR and 
PDGFR, CSF1R does not phosphorylate PLC?I [9]. 
Proliferation of mouse bone marrow.derived 
macrophages and other receptor-bearing cells in. 
response to CSFI is not accompanied by inositol lipid 
breakdown or rapid release of Ca z÷ from intracellular 
stores [10,11]. Recently, CSFI has been shown to 
stimulate phosphatidylcholine hydrolysis and protein 
kinase C activation in human peripheral blood 
monocytes [12], suggesting that the receptor utilizes 
alternative signalling pathways compared with 
PDGFR. We showed recently that CSFI treatment of a 
mouse myeloid progenitor line expressing transfected 
human CSF1R eDNA stimulates mitogenicity and par- 
tial macrophage differentiation [13]. To distinguish be- 
tween pathways generally activated by CSFIR from 
those that might be macrophage-specific, mouse NIH 
3T3 fibroblasts transfected with wild-type and mutant 
human CSF!R cDNAs were examined ill this report. 
We show that CSFIR can couple to PC hydrolysis in 
fibroblasts which do not normally express endogenous 
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CSF I  Rand also thai the K! domain ,  which may affect 
receptor=substrate in|er~ction:s [3,41. is dispensable for 
CSF I  R-induced PC hydrolysis .  
2~ MATERIALS  AND METHODS 
2,1 M#l¢ti~d~ 
Re¢ombt,an! human CSFI tlol no. ~I~322A, a¢tlvily !1.10 U/,,I] wa~ 
from Cellular Produet~. (Buffalo. N.Y.I. Geni~tetn wa~ from 
Ahlrlel~. l~tlhllycerol and [~HlPlto~phatldyl¢l~oline w re from New 
Enilland Nn¢lear. All other rea~nt~ were analytical ~tade. 
2,2, Cell lil¢¢,,~ 
Mouse NIH 3T3 fibroblast,~ (a kind ~lifl of R.A, Welnberl0 were 
grown in Dulbec¢o% modified Eagle medium ¢onlaininl/ 10% fetal 
hovtne ~erum. Mouse NIH ;IT3 ,;ells Iran~f¢¢t~d with httn'~an CSFI R 
eDNA (2-9 Cells) have been described 1,~, 14], A 67 amino a~i(l KI do- 
main deletion mutant (GIy.684) wa~ constrnc~ll/d by ill vitro site 
directed mutallenesl~ as described Jill, This mutated eDNA wa~ 
ttansfected into NIH 3T3 cells to e~tabli~h tire mutant receptor ex- 
pr~s~in$ line (IAIA, 1:~1). All tran~feeted ¢ell lines were ~rown in 
DMEM pltl~ 10% fetal bovine serum in the presence of 0,8 m~/ml 
G-418, to ~¢lect for the nee gene present in Ihe expresfion vector. Tire 
cells were made quiescent b~ incubating confluent monolayers in 
medium containinl~ 0.~0 serum for 20 h. Qiueseent cells were 
slimulated with 1000 U/ml CSFI. 
2,3, Analysis of it~ vivo D/IG production 
The cells were labeled in [~Hlglyceroi (8/~Cilml) for 48 h and then 
starved for serum in medium containing 0,5% dialyzed fetal bovine 
serum plus [~H]glycerol for 20 h. The cells were ~timulated with 1000 
Ulml CSF I. At indicated time points the cell monolayer was extracted 
with 540,ul of 1 N HCI/MeOH/CHCI t(1: 1:1). The aqueous layer was 
extracted with the same solvent mixture, The pooled organic phase 
was dried under a stream of nitrogen and resuspended in 15 t~l of 
CHCh containinl~ cold DAG standard and analyzed on silica gel 60 
thin layer clwomatography plates using a benzene/ethyl acetate (7:3) 
solvent [16]. The DAG was visualized by spraying tile plates with 
p-2.toluidinylnaphthalene-6-sulphonic acid and UV irradiation, The 
corresponding DAG spots in experimental samples wer,.' scraped and 
counted in aquasol, 
2.4. Phospholipase C assay 
CSFl-stimulated cells were lysed in RIPA buffer (20 mM Tris-HCI 
pH 7,5, 150 mM NaCI. 5 mM EDTA, 107o NP.40, I mM Na.~VO~, 1
mM PMSF and 0.25°7o aprotinin) at 4°C for 30 rain, The cell extract 
was centrifuged at 10000 × g for 30 rain. Protein concentration f the 
supernataat was determined using BCA reagent (Pierce Chemical 
Co,). Equal amounts of protein were used in a PLC assay employing 
[aH]PC (choline-methyl [aH]PC) as described by Koran and Parker 
[17], Briefly, the RIPA lysate was incubated with ['~H]PC in PLC 
assay buffer (100 mM NaCI, 0.6% Na-deoxycholate, 2 mM CaCI2, 4 
mM EGTA, 5 mM 2-mercaptoethanol and 20 mM Tris-maleate pH 
6.0) at 37°C for 30 min. The reaction was extracted with 0.5 ml of 
CHCIa/MeOH/ll,6 N HCI (100:100:0,6) and 0.15 ml of I N HCI 
The aqueous layer was routinely counted. Measured amounts of the 
aqueous layer were dried under vacuum and resuspended in cold 
phosphoryleholine standard solution and analyzed on TLC using 
0,50/0 NaCI/MeOH/NH40H [18] as a solvent, The phosphoryl- 
choline standard was visualized by spraying the plates with Dragen- 
dorff's reagent, scraped off the plate and counted. 
2,5. Western blot analysis 
Cell Iysates were analyzed by SDS polyacrylamide gel elec- 
trophoresis. The separated proteins were transferred onto nitro- 
cellulose membrane and probed with a rabbit anti.c.fms antibody, 
The bound antibody was detected by [~2~l].protein A essentially as 
described [13]. 
3. RESULTS AND DISCUSSION 
Act ivat ion or Pl.specif i¢ pho~pholipase C, observed 
after st imulation or  many  cell ~,url'aee reeeptor~ ['/,81, 
does not accompany CSFl . induced micollenesls in bone 
marrow-der ived macrophal~es II01, Chinese hamster 
lunt  cells and N IH  3T3 cells expressing human CSF IR  
also do  not ~how sight ricant P[ hydrolysis in response to 
CSFI  a l though CSF1 is mito~enic in these cells [3,1 I] 
(Ghosh Choudhury ,  unpublished). The  observat ions 
are consistent with the inability o f  CSF IR  to phos-  
phorylate Pl.sp¢cif ic PLC? I  191, an event correlated 
with st imulat ion of PLC~I  activity in other  systems [8]. 
In the absence of  P I  hydrolysis s~veral agonists can 
elicit their effects through hydrolysis o f  other mere. 
brahe phosphol ipids [19]. To determine if transf.ected 
CSF!  R can couple to another phosphol ip id breakdown 
pathway,  we studied DAG product ion in  2 -9  cells. The  
cells were metabolically labelled with [~H]glycerol, sti- 
mulated with human recombinant CSF I  and intra- 
cellular levels o f  DAG were measured at different time 
points (Fig. IA), CSFl -st imulated DAG product ion in 
vivo was significantly elevated at the earliest time point 
examined (80 s), The  intracellular DAd level peaked at 
4 rain o f  human CSF I  st imulation and remained 
elevated at 12 rain, To  determine if. DAG product ion  
was associated with PC hydrolysis, we stimulated c lone 
2-9  cells with human CSFI  fo r  varying periods o f  t ime 
and the cleared cell extracts were assayed for  PC  
hydro lyz ing activity in vitro (Fig. 1B). Human CSF I  
st imulated PC hydrolysis in 2-9 cells with kinetic~ 
similar to those obtained for m r ive DAG product ion 
(Fig. IA) .  These studies provide evidence that, in the 
absence o f  PI turnover,  CSFI  can stimulate the PC  
hydrolysis to  produce second messengers. The  DAG 
produced in this reaction might st imulate protein kinase 
C as a CSF1 induced signalling event in transfected 
f ibroblasts, as has been sho~vn for  peripheral b lood 
monocytes  [12], 
Recently the isoflavone derivative, genistein, has 
been shown to inhibit the tyrosine kinase activity o f  
EGFR and PDGFR and to block their biological activi- 
ty [20-221. Like these receptors, the biological 
responses mediated by CSF1R also depend upon its in- 
trinsic tyrosine kinase activity. We tested if genistein 
could inhibit CSF l - induced PC hydrolys is  in 2--9 cells. 
The cells were treated with 100 /zM genistein and 
st imulated with human CSF1 for 4 rain. The cleared cell 
lysate was tested for PLC  activity in vitro using [3H]PC 
as a substrate. Genistein signif icantly inhibited 
CSF l - induced phosphorylchol ine product ion  f rom PC 
(Fig. 2), suggesting that the tyrosine kinase activity of  
CSF1R is necessary for CSF l - induced PC  hydrolysis. 
The h~ghly hydrophi l ic KI domains  o f  PDGFRB and 
CSF IR  appear to be important in receptor funct ion,  
perhaps in substrate recognition [3,4,23-25],  In the case 
o f  PDGFRB a KI deletion mutant  is dramatical ly ira- 
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Fig. I. CSl.'l.indueed PC hydrolysis in 2-9 cells. (A) [~H}lllyeerol 
labe etl quiescent 2-9 cells were stimulated with 100(3 Utml lumvtn 
recombhlant CSFI, At in(lica~ed t|m~ the cell n~enola~,'cr v,.a~ cx~ 
tracted with CHCI~/MeOH/I N HCI (!:1:1] and the DAG level wn~ 
determined as described in section 2. Each point ix a mean of 
duplicate determination, {B) Quiescent cell monolayer,~ were 
stimulated witl~ 1000 U/ml CSFI At indicated time points the celts 
were lysed and 32.,~ of c¢11 extract was assayed for PLC activity usinl~ 
[~H]PC as a substrate as described in section 2. The data are plotted 
as percent of total cpm in the aqueous extract, The t~asal value of PLC 
activity at time zero wa,~ 381 ± 14 cpm. 
paired in stimulating mitogenesis and in its association 
with at least two cytoplasmic proteins, Ptdlns-3 kinase 
and ras  GTPase activating protein [23,24]. Mouse and 
human CSF1R mutants devoid ¢3f the KI domain do not 
associate well with Ptdlns-3 kinase and are mitogeni- 
caIIy impaired in transfected fibroblasts [3,4,25]. 
Furthermore, two major tyrosine autophosphoryla- 
tion sites have been mapped in the KI domain of the 
mouse receptor (the positions of the homologous 
residues in human CSFIR are Y699 and Y708) [26,27] 
(Fig.3A). We e×pressed a 67 amino acid KI domain 
deletion mutant (Gly-684), spanning from glycine 684 
to leucine 750, in NIH 3T3 cells [3]. Fig. 3B compares 
the mutant CSF1R protein with wild-type CSFIR (in- 
dicated by arrows), and as enpected, the fully processed 
form of the mutant protein is 8 kDa smaller than the 
wild-type receptor (compare lanes 2 and 3, Fig. 3B). 
This cell line (clone 1A1A) expressing the KI domain 
" f • oo g I m 
Fire, 2, Eff¢cz of t~enlst¢in on PC h~,'droly~l,t In 2=9 ¢~Ils. Qut<~¢em 2-9 
eell~ were Irented with 100pM 8enl~t¢ln for 2 h gnd slhnul~l~d with 
CSFI I'or 4 rain, lywd ill RIPA buffer and ~2 #j  el" ¢¢11 lyiaze will 
mtsayed ror PI,,C a~tlvhy u~lnll [~HIPC a~a ~tlb,~lrale. After organic 
¢~mtctio, Ih~ atlU¢OUs Iilyer w~ =milly~ed on TLC to dele~l 
pho~phoryld~oltne ttx tlestribed In ~¢¢iion 2. t-latel)ed anti dark bar~ 
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Fig. 3. Western blot analysis of wild-type and mutant CSFIR protein, 
and coupling of mutant o PC hydrolysis, (A) Structure of the wild- 
type and IKI domain deletion mutant receptors, 'TM' is the transme]n. 
brane domain; dark bars are the tyrosine kinase domain. The major 
m vivo tyro~ine autophosphorylation sites are indicated (residues 699 
and 7fl8). (B) Equal amounts of cell lysate were separated on a 7,5% 
SDS polyacrylamide g l, transferred onto a nitrocellulose filter attd 
probed with a rabbit anti-c-f ms antibody as described in section 2. 
Lane 10 NIH 3T3 cells; Lane 2, cell line IAIA expressing CSFIR KI 
domain deletion mutant; Lane 3, wild type receptor expressing line 
(2-9). Arrows indicate the mature forms of mutant receptor protein 
(142 kDa) and wild.type receptor protein (150 k Da) (C) PC hydrolysis 
in clone 1A 1A cells. The quiescent cell monolayer was stimulated with 
I000 U/ml CSFI for 4 rain. lyscd in RiPA buffer, then 32..g of cell 
extract was as~ayed for PLC activity in vitro using [3H]PC as 
substrate. After organic extraction the aqueous layer was analyzed for 
phosphorylclmline as described in section 2. ' - '  and ' ~- ' are in the 
absence and presence of CSFI. respectively. 
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deletion mutant was ~llmul:ated with huma~ CSF|, and 
the cell lysate wa~ tested forPC hydrolysis in vitro, "/'he 
data (Fig,, 3C) show tim{ CSFI ~timulates PLC activity 
cleaving PC in clone IAIA cells. The extent of PC 
hydrolysis el;~.:¢¢d by the Gly.684 ddetion mutant was 
consistently lower than that obtained with wild-type 
receptor, In 5 experiments the mean told-increase in 
CSFl-induced PC hydrolysis over basal activity in 2.-9 
cells was 4,97, while that for Gly.684 was 3,20, The 
decrease obtained witl~ the GIy.684 deletion mutant 
might bc due in part to the slightly lower expression of 
receptor protein compared to tl~e wild-type receptor ex- 
pressing line (Fig, 3B, compare lanes 2 and 3; and 13}). 
It is presumed, however, that despite the likely et'fect on 
the conformation or the cytoplasmic domain, deletion 
of  the CSFI R K[ segment has not abrogated the ability 
of  the receptor to stimulate the PC hydrolysis patlaway. 
The mechanism(s) coupling CSFIR to PC hydrolysis 
and the role(s) of this phospholipid hydrolysis pathway 
in CSFl-induced growth and differentiation are cur- 
rently under investigation. 
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